Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines |
| |
Authors: | Joshua Tobias Ann-Mari Svennerholm Jan Holmgren Michael Lebens |
| |
Affiliation: | (1) University of Gothenburg Vaccine Research Institute (GUVAX), P.O. Box 435, 40530 Gothenburg, Sweden;(2) WHO Collaborating Center for Research on enterotoxigenic Escherichia coli (ETEC), P.O. Box 435, 40530 Gothenburg, Sweden;(3) Department of Microbiology and Immunology, The Sahlgrenska Academy of University of Gothenburg, P.O. Box 435, 40530 Gothenburg, Sweden;(4) Department of Microbiology and Immunology, University of Gothenburg, P.O. Box 435, 40530 Gothenburg, Sweden |
| |
Abstract: | Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrheal morbidity in developing countries, especially in children and also of traveler's diarrhea. Colonization factors (CFs) of ETEC, like CFA/I and CS2 which are genetically and structurally related, play a substantial role in pathogenicity, and since intestinal–mucosal immune responses against CFs appear to be protective, much effort has focused on the development of a CF-based ETEC vaccine. We have constructed hybrid operons in which the major CS2 subunit-encoding cotA gene was inserted into the CFA/I operon, either replacing (hybrid I) or being added to the major CFA/I subunit-encoding cfaB gene (hybrid II). Using specific monoclonal antibodies against the major subunits of CFA/I and CS2, high levels of surface expression of both fimbrial subunits were shown in E. coli carrying the hybrid II operon. Oral immunization of mice with formalin-killed bacteria expressing hybrid II fimbriae induced strong CFA/I- and CS2-specific serum IgG + IgM and fecal IgA antibody responses, which were higher than those achieved by similar immunization with the reference strains. Bacteria expressing hybrid fimbriae are potential candidate strains in an oral-killed CF-ETEC vaccine, and the approach represents an attractive and novel means of producing a broad-spectrum ETEC vaccine. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|